India has expanded its diplomatic footprint in the U.S. Pacific Northwest with the opening of a new Indian Consular ...

The Department of Social Welfare and Development (DSWD) has warned the public against unauthorized individuals or groups offering assistance in the processing of travel clearance (TC) for minors ...

Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveraging its first-in-class Flare platform, today announced that the U.S. Food and Drug Administration (FDA) has ...

Earlier this week, social media was abuzz over yet another traffic-related issue. This time, it involved transport blogger, James Deakin, and the LTO.

HONG KONG, Jan. 5, 2026 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food ...

SYX-5219 is a first-in-class oral PKM2 modulator designed to drive sustained disease remission across a range of autoimmune diseases Phase 1b trial to investigate the safety, tolerability and initial ...

Avenzo Therapeutics, Inc. (“Avenzo”), a clinical-stage biotechnology company developing next-generation oncology therapies, today announced clearance by the U.S. Food and Drug Administration (FDA) of ...

MANILA, Philippines – The irrevocable resignation submitted by National Bureau of Investigation (NBI) Director Jaime Santiago is now “for acceptance,” Malacañang said on Wednesday. Presidential ...

– Phase 1/2 trial expected to initiate in 2H 2025 in patients with BEST1 inherited retinal disease RESEARCH TRIANGLE PARK, N.C., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Opus Genetics (Nasdaq: IRD), a ...

CAMBRIDGE, Mass., Aug. 7, 2025 /PRNewswire/ -- K36 Therapeutics, Inc. ("K36"), a privately held clinical-stage biotechnology company developing novel, targeted therapies for cancers with unmet medical ...